Part 3 - Muscle Relaxants Flashcards

(30 cards)

1
Q

Muscle Relaxants Primary Goals

A

Selectively decrease skeletal muscle excitability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Muscle Relaxants Primary Uses

A

Muscle Spasms and spasticity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Muscle Spasms

A

Usually injury to mm or peripheral nn causing tonic contraction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Spasticity

A

CNS lesion that causes an exaggerated stretch reflex. Often velocity dependent.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Types of agents used to treat muscle spasms

A

Centrally acting anti-spasm drugs

Diazapam (Valium)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Centrally acting anti-spasm drugs

A

Diverse group

Used commonly in back and neck spasms; other ortho injuries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Common Central antispasm drugs

A
Carisoprodol
Chlorzoxazone
Cyclobenzaprine
Metaxalone
Methocarbarbamol
Orphenadrine Citrate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Centrally-acting anti-spasm drugs primary effect

A

Strong sedatives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Carisoprodol MOA

A

Enhances GABA inhibition in brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cyclobenzaprine MOA

A

Might increase serotonin in the brainstem

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Antispasm drugs bottom line

A

Short term use for acute spasms
Patients may decide to take at bedtime
Combine with aggressive PT
Should be discontinued ASAP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Diazepam (Valium)

A

Developed originally as an antianxiety drug

Works in CNS to increase inhibitory effects of GABA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

GABA Receptor

A

Has binding sites for GABA, Benzo, Barbituates
Chloride channel in the center
Chloride is normally inhibitory
Valium keeps GABA bound longer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Valium effects

A

Increases GABA mediated inhibition of alpha motor neuron
Less excitation leads to muscle relaxation
Used in spasms and spasticity, but causes sedation
Long-term use limited by tolerance and dependence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Agents used to treat spasticity

A
Diazepam
Baclofen
Alpha-2 agonists
Gabapentin
Dantrolene
Botulinum toxin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Baclofen

A

Synthetic GABA
Stimulates GABA receptors in cord
Decreases excitation of alpha motor neuron
Can be administered intrathecally

17
Q

Intrathecal Baclofen

A

Used in severe spasticity
Catheter and pump deliver drug to subarachnoid space
May decrease spasticity with less drug, fewer side effects

18
Q

Intrathecal baclofen signs of OD

A

Decreased respiration
Decreased cardiac function
Stupor
Coma

19
Q

Intrathecal baclofen signs of withdrawal

A

Fever
Confusion
Hallucinations
Seizures

20
Q

Alpha-2 agonists

A

Primarily tizanidine
Stimulates alpha-2 receptors located on spinal interneurons
Causes inhibition of interneurons; decrease excitation on alpha motor neuron
Efficacy similar to oral baclofen but less generalized mm weakness

21
Q

Gabapentin (Neurontin)

A

Developed as antiseizure drug
Inhibits Ca++ entry presynaptic terminal; decreased release of glutamate
Used primarily in MS, SCI.
May cause sedation, dizziness, ataxia

22
Q

Dantrolene Sodium (Dantrium)

A

Only direct-acting muscle relaxant
Inhibits release of calcium from skeletal mm SR
Problems with liver toxicity; esp women over 35

23
Q

Botulinum toxin

A
Muscle paralytic...Injected locally for severe spasms such as torticollis
Increased use in spasticity
7 serotypes, 2 used clinically
-Type A (Botox, Dysport, Xeomin)
-Type B (Myobloc)
24
Q

Botulinum toxin MOA

A

Inhibits release of ACh at skeletal neuromuscular junction by eating connection proteins so no exocytosis of ACh

25
Botulinum toxin antispasticity effects
``` Injected into selected muscle Relaxation occurs within 3 to 7 days; lasts 2 to 3 months Reduces spastic dominance -Increases residual function -Improved ADL, braces fit better, etc ```
26
Botulinum toxin effects
BTX may be transported to CNS (retrograde transmission) | May produce carry-over & long term effects on activity in cord and brain
27
Limitations of botulinum toxin
Local irritation at injection site Potential for antibody production Must limit total dose
28
Botulinum toxin total dose
300-400 Units/tx Type A | 2500-5000 Units/Tx Type B
29
BTX signs of OD
Drooping eyes Difficulty speaking/swallowing General muscle weakness Respiratory distress
30
Muscle relaxants rehabilitation concerns
Generalized weakness Sedation Possible drastic change in spasticity over relatively short time span